CBD should not be scheduled within international drug control conventions, according to the latest meeting of the World Health Organization (WHO)’s Expert Committee on Drug Dependence (ECDD).

The 40th meeting of the ECDD focused on a review of cannabis and its component substances. During a critical review of evidence it established that CBD did not have psychoactive properties, and presented no potential for abuse or dependence.

The CBD investigation found that CBD did not appear to create THC-like effects and thus “generally the effects of CBD do not indicate the likelihood for abuse”.

“In a randomized, double-blind study using cannabis smokers, CBD administered by itself up to 800 mg produced no significant psychoactive, cardiovascular or other effects and was without abuse-related indicators in a variety of tests,” it said.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us